Azala

The Immunology and Biology of Brain Tumors

Immunotherapy has become a viable treatment modality for a variety of cancers (and referred to as Science Magazine’s “Breakthrough of the Year” in 2013, as well as ASCO’s “Advance of the Year” in both 2016 and 2017). This Special Issue is focused on the relevance of immunobiology in brain tumors, to...

Deskribapen osoa

Gorde:
Formatua: Online
Hizkuntza:ingelesa
Argitaratua: MDPI - Multidisciplinary Digital Publishing Institute 2022
Gaiak:
vaccine therapy
oncoantigen
tumor associate antigen
tumor angiogenesis
high-grade glioma
pituitary neuroendocrine tumors
VEGF
Treg
TAM
PD-1
PD-L1
tumor microenvironment (TME)
glioblastoma multiforme (GBM)
GBM-associated macrophages (GAMs)
exosomes
oncomiR-21
STAT3 inhibitor
glioma
diffusion tensor imaging
generalized q-ball imaging
treatment-related effects
multiple resections
adrenal insufficiency
Addison’s disease
bevacizumab
cerebral radiation necrosis
craniopharyngioma
inflammation
checkpoint inhibitors
Interleukin-6
thema EDItEUR::M Medicine and Nursing
Sarrera elektronikoa:ONIX_20220111_9783036501024_11
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
Gaia:Immunotherapy has become a viable treatment modality for a variety of cancers (and referred to as Science Magazine’s “Breakthrough of the Year” in 2013, as well as ASCO’s “Advance of the Year” in both 2016 and 2017). This Special Issue is focused on the relevance of immunobiology in brain tumors, touching on elements of immune suppression, immune stimulation, and the immune microenvironment, with culminations in translational immunotherapy.

Antzeko izenburuak